This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Published Erratum

. 2025 Aug 4;13(8):831.

doi: 10.3390/vaccines13080831.

Correction: Feemster et al. Implications of Cross-Reactivity and Cross-Protection for Pneumococcal Vaccine Development. Vaccines 2024, 12, 974

Kristen Feemster¹, William P Hausdorff^{2

3}, Natalie Banniettis¹, Heather Platt¹, Priscilla Velentgas¹, Alejandra Esteves-Jaramillo¹, Robert L Burton⁴, Moon H Nahm⁵, Ulrike K Buchwald¹

Affiliations

Affiliations

¹ Merck & Co., Inc., Rahway, NJ 07065, USA.
² Center for Vaccine Innovation and Access, PATH, 455 Massachusetts Ave NW, Washington, DC 20001, USA.
³ Faculty of Medicine, Université Libre de Bruxelles, 1050 Brussels, Belgium.
⁴ SunFire Biotechnologies LLC, Birmingham, AL 35203, USA.
⁵ Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL 35233, USA.

PMID: 40872973
PMCID: PMC12390168
DOI: 10.3390/vaccines13080831

Published Erratum

Correction: Feemster et al. Implications of Cross-Reactivity and Cross-Protection for Pneumococcal Vaccine Development. Vaccines 2024, 12, 974

Kristen Feemster et al. Vaccines (Basel). 2025.

. 2025 Aug 4;13(8):831.

doi: 10.3390/vaccines13080831.

Authors

Kristen Feemster¹, William P Hausdorff^{2

3}, Natalie Banniettis¹, Heather Platt¹, Priscilla Velentgas¹, Alejandra Esteves-Jaramillo¹, Robert L Burton⁴, Moon H Nahm⁵, Ulrike K Buchwald¹

Affiliations

¹ Merck & Co., Inc., Rahway, NJ 07065, USA.
² Center for Vaccine Innovation and Access, PATH, 455 Massachusetts Ave NW, Washington, DC 20001, USA.
³ Faculty of Medicine, Université Libre de Bruxelles, 1050 Brussels, Belgium.
⁴ SunFire Biotechnologies LLC, Birmingham, AL 35203, USA.
⁵ Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL 35233, USA.

PMID: 40872973
PMCID: PMC12390168
DOI: 10.3390/vaccines13080831

Abstract

The authors would like to make the following corrections to this published paper [...].

PubMed Disclaimer

Erratum for

Implications of Cross-Reactivity and Cross-Protection for Pneumococcal Vaccine Development.
Feemster K, Hausdorff WP, Banniettis N, Platt H, Velentgas P, Esteves-Jaramillo A, Burton RL, Nahm MH, Buchwald UK. Feemster K, et al. Vaccines (Basel). 2024 Aug 28;12(9):974. doi: 10.3390/vaccines12090974. Vaccines (Basel). 2024. PMID: 39340006 Free PMC article. Review.

References

1. Feemster K., Hausdorff W.P., Banniettis N., Platt H., Velentgas P., Esteves-Jaramillo A., Burton R.L., Nahm M.H., Buchwald U.K. Implications of Cross-Reactivity and Cross-Protection for Pneumococcal Vaccine Development. Vaccines. 2024;12:974. doi: 10.3390/vaccines12090974. - DOI - PMC - PubMed

Publication types

Actions

LinkOut - more resources

Full Text Sources
- MDPI
- PubMed Central